Talar Tokatlian

Talar Tokatlian has a strong background in scientific research and drug discovery. Talar is currently working at A2 Biotherapeutics, Inc. as a Principal Scientist, focusing on drug discovery. Prior to this role, they served as a Senior Scientist, also in drug discovery, at the same company. Before joining A2 Biotherapeutics, Talar worked as a Scientist II, specializing in Biology and Immunology, also in drug discovery, at the company. Talar gained significant research experience during their time at the Massachusetts Institute of Technology, where they held the position of Postdoctoral Research Associate in the lab of Darrell J. Irvine. Their research focused on the design of nanoparticles for vaccines, particularly HIV vaccine design. Talar further expanded their research expertise during their time as a Graduate Student Researcher at the University of California, Los Angeles, and as a Graduate Intern at Novartis Institutes for Biomedical Research. Talar began their research career as an Undergraduate Student Researcher at the University of California, Berkeley. Overall, Talar Tokatlian has a diverse and impressive work experience in scientific research and drug discovery.

Talar Tokatlian has a strong educational background in Chemical Engineering. From 2003 to 2007, they pursued their Bachelor of Science degree at the University of California, Berkeley, specializing in Chemical Engineering with an emphasis in Biotechnology. Talar furthered their academic journey by pursuing a Ph.D. in Chemical Engineering at UCLA from 2007 to 2012.